Literature DB >> 16265885

Quinolines and artemisinin: chemistry, biology and history.

P G Bray1, S A Ward, P M O'Neill.   

Abstract

Plasmodium falciparum is the most important parasitic pathogen in humans, causing hundreds of millions of malaria infections and millions of deaths each year. At present there is no effective malaria vaccine and malaria therapy is totally reliant on the use of drugs. New drugs are urgently needed because of the rapid evolution and spread of parasite resistance to the current therapies. Drug resistance is one of the major factors contributing to the resurgence of malaria, especially resistance to the most affordable drugs such as chloroquine. We need to fully understand the antimalarial mode of action of the existing drugs and the way that the parasite becomes resistant to them in order to design and develop the new therapies that are so urgently needed. In respect of the quinolines and artemisinins, great progress has been made recently in studying the mechanisms of drug action and drug resistance in malaria parasites. Here we summarize from a historical, biological and chemical, perspective the exciting new advances that have been made in the study of these important antimalarial drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16265885     DOI: 10.1007/3-540-29088-5_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  21 in total

Review 1.  Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.

Authors:  Ernst Hempelmann
Journal:  Parasitol Res       Date:  2006-11-17       Impact factor: 2.289

2.  Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.

Authors:  Lindi Roberts; Timothy J Egan; Keith A Joiner; Heinrich C Hoppe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

3.  Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.

Authors:  Xiaohong Peng; Gladys J Keitany; Marissa Vignali; Lin Chen; Claire Gibson; Kimberly Choi; Fusheng Huang; Ruobing Wang
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

4.  Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.

Authors:  Monika Chugh; Vidhya Sundararaman; Saravanan Kumar; Vanga S Reddy; Waseem A Siddiqui; Kenneth D Stuart; Pawan Malhotra
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

5.  PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.

Authors:  Vito W Rebecca; Michael C Nicastri; Colin Fennelly; Cynthia I Chude; Julie S Barber-Rotenberg; Amruta Ronghe; Quentin McAfee; Noel P McLaughlin; Gao Zhang; Aaron R Goldman; Rani Ojha; Shengfu Piao; Estela Noguera-Ortega; Alessandra Martorella; Gretchen M Alicea; Jennifer J Lee; Lynn M Schuchter; Xiaowei Xu; Meenhard Herlyn; Ronen Marmorstein; Phyllis A Gimotty; David W Speicher; Jeffrey D Winkler; Ravi K Amaravadi
Journal:  Cancer Discov       Date:  2018-11-15       Impact factor: 39.397

6.  In vivo antimalarial activity of the endophytic actinobacteria, Streptomyces SUK 10.

Authors:  Mohd Shukri Baba; Noraziah Mohamad Zin; Zainal Abidin Abu Hassan; Jalifah Latip; Florence Pethick; Iain S Hunter; RuAngelie Edrada-Ebel; Paul R Herron
Journal:  J Microbiol       Date:  2015-12-02       Impact factor: 3.422

7.  Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?

Authors:  Qin Cheng; Dennis E Kyle; Michelle L Gatton
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-27       Impact factor: 4.077

8.  Zinc triflate: a highly efficient reusable catalyst in the synthesis of functionalized quinolines via Friedlander annulation.

Authors:  Kushal C Lekhok; Debajyoti Bhuyan; Dipak Prajapati; Romesh C Boruah
Journal:  Mol Divers       Date:  2009-12-05       Impact factor: 2.943

9.  Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum.

Authors:  Margaret A Phillips; Ramesh Gujjar; Nicholas A Malmquist; John White; Farah El Mazouni; Jeffrey Baldwin; Pradipsinh K Rathod
Journal:  J Med Chem       Date:  2008-06-04       Impact factor: 7.446

Review 10.  Artemisinins: their growing importance in medicine.

Authors:  Sanjeev Krishna; Leyla Bustamante; Richard K Haynes; Henry M Staines
Journal:  Trends Pharmacol Sci       Date:  2008-08-25       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.